Decheng Capital

Decheng Capital is a venture capital firm that provides capital and strategic support to early and growth-stage life science companies with revolutionary technologies and strong market presence. Founded in 2012, the firm manages over $2 billion in capital and has a team of dedicated professionals with complementary expertise, aiming to build highly successful companies globally.

The firm's investment strategy focuses on sectors such as healthcare, life sciences, biotech, diagnostics, medical devices, and life science tools. Decheng Capital invests across various stages, including seed, early, growth, and public companies, with investment sizes ranging from $1 million to $50 million.

With offices in Menlo Park, California, Shanghai, China, and New York, New York, Decheng Capital leverages its global presence to support entrepreneurs and create value for investors. The firm has a track record of successful investments in companies like Cellares Corporation, Mammoth Biosciences, and Grail, Inc.